‘Rare Impact Awards’ Dinner Marks Orphan Drug Act and NORD at 35
The National Organization for Rare Disorders (NORD) will celebrate the 35th anniversary of both the 1983 Orphan Drug Act and…
Articles by Larry Luxner
#ECRD2018 – EU Must Do More for Rare Disease Patients, Eurordis Leaders Say
The European Union isn’t doing enough to protect the 30 million or so people with rare diseases who live in…
#ECRD2018 – Patient Access and Collaboration Focus of Eurordis Meeting May 10-12
At least 800 people representing some 45 countries are soon expected to gather in Austria’s capital city, Vienna, for…
NIH Agency Pioneers Collaborative Research into Rare Diseases
A little-known government entity within the National Institutes of Health (NIH) is helping to lead U.S. efforts to speed…
Genome Sequencing and Its Clinical Potential Focus of NYC Rare Disease Day Event
Genetic sequencing and the speed with which it can help diagnose a child’s disease — in addition to revealing the genes…
‘A Disease May Be Rare, Hope Should Never Be,’ Says Boy with SMARD at Connecticut Rare Disease Day Event
When it comes to rare diseases, one that definitely makes the list is spinal muscular atrophy with respiratory distress —…
Rare Disease Groups Welcome FDA’s Embrace of ‘Real World’ Data in Clinical Trials
In his 10 months on the job, Commissioner Scott Gottlieb of the U.S. Food and Drug Administration is earning…
US Lawmakers Urge Bipartisan Support for Rare Disease Research, Patients’ Needs
At a time of unprecedented polarization in Congress, two U.S. lawmakers — one Republican, one Democrat — are stressing the urgency…
Retrophin, Horizon Donate $3M Each to Rare Disease Institute at Children’s National
Retrophin and the U.S. subsidiary of Britain’s Horizon Pharma will each donate $3 million over a six-year period to…
Bionews to Cover 3 Rare Disease Day Events, Including NIH Conference
In recognition of Rare Disease Day 2018, Bionews Services — which publishes this website — will attend and…